SCHEMBL6774777

SCHEMBL6774777

NS(=O)(=O)Cc1ccco1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA5A P35218 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ CA12 O43570 1/20 0.44
▸ CA4 P22748 1/20 0.44
▸ ALOX5 P09917 1/20 0.43
▸ ALDH1A1 P00352 6/20 0.41
▸ MAPT P10636 2/20 0.41
▸ POLB P06746 3/20 0.40
▸ LMNA P02545 3/20 0.40
▸ TSHR P16473 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27495770 0.98 CA1 (0.43) CA1CA2CA5ACA9CA12
Furan SCHEMBL6776506 0.92 CA1 (0.40) CA1CA2CA5ACA9CA12
SCHEMBL28198347 0.79 CA12 (0.45) CA1CA2CA9CA12CA4
SCHEMBL2376319 0.78 ALDH1A1 (0.47) ALDH1A1MAPTPOLBLMNATSHR
SCHEMBL4016648 0.78 EPHX2 (0.44) ALOX5ALDH1A1MAPTPOLBLMNA
SCHEMBL6384320 0.78 ALDH1A1 (0.40) ALOX5ALDH1A1MAPTPOLBLMNA
SCHEMBL2376313 0.78 ALDH1A1 (0.40) ALOX5ALDH1A1MAPTPOLBLMNA
SCHEMBL6650100 0.77 POLB (0.44) ALDH1A1MAPTPOLBLMNATSHR
SCHEMBL9274608 0.74 ALDH1A1 (0.51) ALDH1A1MAPTPOLBLMNATSHR
SCHEMBL14380630 0.74 ALDH1A1 (0.55) CA1CA2CA12CA4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6767906-B2 INHIBIT P34CDC2/CYCLIN BCDC13 KINASE AND PROTEIN TYROSINE KINASE PP60C-SRC AND CAN BE USED FOR TREATMENT OF HYPERPROLIFERATIVE DISEASES, FOR EXAMPLE CHEMOTHERAPY OF TUMOURS OR OSTEOPOROSIS. NOVARTIS AG (CH) 2004-07-27 — — US disclosed
EP-1299122-A2 COMBINATION OF A COX-2 INHIBITOR AND A VASOMODULATOR FOR TREATING PAIN AND HEADACHE PAIN Pharmacia Corporation (US) 2003-04-09 — — EP disclosed
WO-2002005799-A2 COMBINATION OF A COX-2 INHIBITOR AND A VASOMODULATOR FOR TREATING PAIN AND HEADACHE PAIN PHARMACIA CORPORATION (US) 2002-01-24 — — WO disclosed
Send feedback